124 related articles for article (PubMed ID: 503893)
21. Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
Klingebiel T; Bader P; Hollatz G; Koehl U; Lehrnbecher T; Meisel R; Dilloo D
Klin Padiatr; 2006; 218(6):355-65. PubMed ID: 17080339
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy by allogeneic stem cell transplantation.
Ringdén O
Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
[TBL] [Abstract][Full Text] [Related]
23. WT1 peptide immunotherapy for cancer in children and young adults.
Hashii Y; Sato E; Ohta H; Oka Y; Sugiyama H; Ozono K
Pediatr Blood Cancer; 2010 Aug; 55(2):352-5. PubMed ID: 20582983
[TBL] [Abstract][Full Text] [Related]
24. [PRAME protein expressed in leukemia cells as a target molecule for immunotherapy].
Ikeda H; Matsushita M; Kawakami H
Rinsho Ketsueki; 1999 Jun; 40(6):484-6. PubMed ID: 10422284
[No Abstract] [Full Text] [Related]
25. Immunotherapy of cancer.
Salmon SE; Jones SE
Ariz Med; 1977 Jun; 34(6):396-8. PubMed ID: 880051
[No Abstract] [Full Text] [Related]
26. Immunotherapy of cancer: theory and practice.
Rapp HJ
Proc Inst Med Chic; 1975; 30(8):251-5, 274. PubMed ID: 1103122
[No Abstract] [Full Text] [Related]
27. Immunotherapy of cancer: a critical review.
Lutz D
Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):118-29. PubMed ID: 6343261
[TBL] [Abstract][Full Text] [Related]
28. Editorial: Prophylactic immunotherapy.
Med J Aust; 1975 Aug; 2(9):332-3. PubMed ID: 241897
[No Abstract] [Full Text] [Related]
29. [Immunotherapy].
Yasukawa M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():230-5. PubMed ID: 23133959
[No Abstract] [Full Text] [Related]
30. Hybridoma monoclonal antibody treatment of T-cell lymphomas: clinical experience and nursing management.
DiJulio JE; Bedigian JS
Oncol Nurs Forum; 1983; 10(2):22-27. PubMed ID: 6346276
[No Abstract] [Full Text] [Related]
31. Chemo-immunotherapy versus chemotherapy in acute leukemia remission induction.
Yu ZF; Lin MF; Wang BC; Lin XJ; Lin XH
Chin Med J (Engl); 1981 Jan; 94(1):31-4. PubMed ID: 6785021
[No Abstract] [Full Text] [Related]
32. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
Castello G; D'Alessio V
Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
[TBL] [Abstract][Full Text] [Related]
33. [Specific active immunotherapy in the treatment of non-lymphoid solid tumours. A study of thirty-one cases (author's transl)].
Simo-Camps E; Vich JM; Anguera A; Manresa F; Puigdollers JM; Manresa G; Salleras V
Sangre (Barc); 1977; 22(3):351-7. PubMed ID: 867213
[No Abstract] [Full Text] [Related]
34. [Immunotherapy of cancer].
Lascano FD; Mazzei JA; Estevez ME
Prensa Med Argent; 1971 Mar; 58(2):75-91. PubMed ID: 4103879
[No Abstract] [Full Text] [Related]
35. [Cellular immunotherapy for hematopoietic malignancies].
Yasukawa M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():390-4. PubMed ID: 17474435
[No Abstract] [Full Text] [Related]
36. [Attempt at immunotherapy using BCG vaccine in acute leukemia].
Kardaszewicz E
Acta Haematol Pol; 1972; 3(3):251-6. PubMed ID: 4649308
[No Abstract] [Full Text] [Related]
37. CANCER IMMUNOTHERAPY. Baby's leukemia recedes after novel cell therapy.
Couzin-Frankel J
Science; 2015 Nov; 350(6262):731. PubMed ID: 26564829
[No Abstract] [Full Text] [Related]
38. Immunotherapy: combine and conquer.
Nat Med; 2015 May; 21(5):415. PubMed ID: 25951522
[No Abstract] [Full Text] [Related]
39. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
Oka Y; Tsuboi A; Sugiyama H
Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
[No Abstract] [Full Text] [Related]
40. Immunotherapy of human tumors.
Sinkovics JG
Pathobiol Annu; 1978; 8():241-84. PubMed ID: 364375
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
